浙江交科(002061.SZ)下屬公司收到相關項目的中標通知書
格隆匯11月14日丨浙江交科(002061.SZ)公佈,2019年11月5日,公司披露了《關於下屬公司項目中標的提示性公告》,浙江交工路橋建設有限公司(“交工路橋”)、浙江交工金築建設有限公司(“交工金築”)在近期參與的臨金高速公路臨安至建德段工程土建施工項目投標,分別為項目第TJ03標段、第TJ04標段第一中標候選人。近日,交工路橋、交工金築分別收到了中標通知書,第TJ03標段中標金額約人民幣15.01億元;第TJ04標段中標金額約人民幣12.34億元。
中標項目符合公司主營業務戰略佈局,能夠鞏固公司在長三角地區的市場競爭力和市場佔有率,若上述中標項目順利實施將對公司未來業績將產生積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.